Abstract
To date, health related quality of life (QoL) has not been systematically evaluated in youth with fragile X syndrome (FXS), the most common single gene cause of autism and the most common inherited form of developmental disability. We describe QoL data gathered using the Pediatric Quality of Life Inventory (PedsQL) completed online by 364 parents of youth with FXS. Parents consistently reported across all gender and age groups that their children experienced the highest QoL in Physical functioning and the lowest QoL in Cognitive functioning. Overall, older children with FXS had increase QoL ratings in the domains of School and Cognitive function.
References
Abbeduto, L., Seltzer, M. M., Shattuck, P., Krauss, M. W., Orsmond, G., & Murphy, M. M. (2004). Psychological well-being and coping in mothers of youths with autism, down syndrome, orfragile X syndrome. American Journal on Mental Retardation,109(3), 237–254.
Alonso, E. M., & Sorensen, L. G. (2009). Cognitive development following pediatric solid organ transplantation. Current Opinion in Organ Transplantation,14(5), 522–525.
Aman, M. G., Burrow, W. H., & Wolford, P. L. (1995). The Aberrant Behavior Checklist-Community: Factor validity and effect of subject variables for adults in group homes. American Journal on Mental Retardation,100(3), 283–292.
Bagni, C., Tassone, F., Neri, G., & Hagerman, R. (2012). Fragile X syndrome: Causes, diagnosis, mechanisms, and therapeutics. The Journal of Clinical Investigation,122(12), 4314–4322.
Bailey, D. B., Raspa, M., & Olmsted, M. G. (2010). Using a parent survey to advance knowledge about the nature and consequences of fragile X syndrome. American Journal on Intellectual and Developmental Disabilities,115(6), 447–460. https://doi.org/10.1352/1944-7558-115.6.447.
Barker, E. T., Hartley, S. L., Seltzer, M. M., Floyd, F. J., Greenberg, J. S., & Orsmond, G. I. (2011). Trajectories of emotional well-being in mothers of adolescents and adults with autism. Developmental Psychology,47(2), 551.
Berry-Kravis, E. (2015). A 6-week, randomized, multicenter, double-blind, parallel, flexed-and fixed-dose study of MDX (Metadoxine Extended-release; MG01CI) Compared with Placebo in Adolescents and Adults with Fragile X Syndrome. In 62nd Annual Meeting, 2015: AACAP.
Berry-Kravis, E. M., Lindemann, L., Jønch, A. E., Apostol, G., Bear, M. F., Carpenter, R. L., et al. (2017). Drug development for neurodevelopmental disorders: Lessons learned from fragile X syndrome. Nature Reviews Drug Discovery,17(4), 280.
Berry-Kravis, E., & Potanos, K. (2004). Psychopharmacology in fragile X syndrome–present and future. Mental Retardation and Developmental Disabilities Research Reviews,10(1), 42–48. https://doi.org/10.1002/mrdd.20007.
Chevreul, K., Berg Brigham, K., Brunn, M., & Portes, V. (2015). Fragile X syndrome: Economic burden and health-related quality of life of patients and caregivers in France. Journal of Intellectual Disability Research,59(12), 1108–1120.
Cummins, R. A. (2005). Moving from the quality of life concept to a theory. Journal of Intellectual Disability Research,49(10), 699–706.
DaWalt, L. S., Usher, L. V., Greenberg, J. S., & Mailick, M. R. (2017). Friendships and social participation as markers of quality of life of adolescents and adults with fragile X syndrome and autism. Autism,23(2), 383–393.
Desai, A. D., Zhou, C., Stanford, S., Haaland, W., Varni, J. W., & Mangione-Smith, R. M. (2014). Validity and responsiveness of the pediatric quality of life inventory (PedsQL) 4.0 generic core scales in the pediatric inpatient setting. JAMA Pediatrics,168(12), 1114–1121. https://doi.org/10.1001/jamapediatrics.2014.1600.
Erickson, C. A., Davenport, M. H., Schaefer, T. L., Wink, L. K., Pedapati, E. V., Sweeney, J. A., et al. (2017). Fragile X targeted pharmacotherapy: Lessons learned and future directions. Journal of Neurodevelopmental Disorders,9(1), 7.
Esbensen, A. J., Rojahn, J., Aman, M. G., & Ruedrich, S. (2003). Reliability and validity of an assessment instrument for anxiety, depression, and mood among individuals with mental retardation. Journal of Autism and Developmental Disorders,33(6), 617–629.
Fitzgerald, M., Birkbeck, G., & Matthews, P. (2002). Maternal burden in families with children with autistic spectrum disorder. The Irish Journal of Psychology,33, 17.
Gray, D. E. (2002). Ten years on: A longitudinal study of families of children with autism. Journal of Intellectual and Developmental Disability,27(3), 215–222.
Hess, L. G., Fitzpatrick, S. E., Nguyen, D. V., Chen, Y., Gaul, K. N., Schneider, A., et al. (2016). A randomized, double-blind, placebo-controlled trial of low-dose sertraline in young children with Fragile X Syndrome. Journal of Developmental and Behavioral Pediatrics,37(8), 619.
Hsieh, R. L., Hsueh, Y. M., Huang, H. Y., Lin, M. I., Tseng, W. C., & Lee, W. C. (2013). Quality of life and impact of children with unclassified developmental delays. Journal of Paediatrics and Child Health,49(2), E116–E121.
Ikeda, E., Hinckson, E., & Krägeloh, C. (2014). Assessment of quality of life in children and youth with autism spectrum disorder: A critical review. Quality of Life Research,23(4), 1069–1085.
Jacquemont, S., Curie, A., Des Portes, V., Torrioli, M. G., Berry-Kravis, E., Hagerman, R. J., et al. (2011). Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. Science Translational Medicine,3(64ra61), 64ra61.
Kamp-Becker, I., Schröder, J., Remschmidt, H., & Bachmann, C. J. (2010). Health-related quality of life in adolescents and young adults with high functioning autism-spectrum disorder. GMS Psycho-Social-Medicine,7, 1–10.
Kuhlthau, K., Orlich, F., Hall, T. A., Sikora, D., Kovacs, E. A., Delahaye, J., et al. (2010). Health-related quality of life in children with autism spectrum disorders: Results from the autism treatment network. Journal of Autism and Developmental Disorders,40(6), 721–729.
Lewis, P., Abbeduto, L., Murphy, M., Richmond, E., Giles, N., Bruno, L., et al. (2006). Psychological well-being of mothers of youth with fragile X syndrome: Syndrome specificity and within-syndrome variability. Journal of Intellectual Disability Research,50(12), 894–904.
Limbers, C. A., Heffer, R. W., & Varni, J. W. (2009). Health-related quality of life and cognitive functioning from the perspective of parents of school-aged children with Asperger’s Syndrome utilizing the PedsQL™. Journal of Autism and Developmental Disorders,39(11), 1529–1541.
Lounds, J., Seltzer, M. M., Greenberg, J. S., & Shattuck, P. T. (2007). Transition and change in adolescents and young adults with autism: Longitudinal effects on maternal well-being. American Journal on Mental Retardation,112(6), 401–417.
Mullen, E. M. (1995). Mullen scales of early learning. Circle Pines, MN: AGS.
Pappas, D. (2006). ADHD Rating Scale-IV: Checklists, norms, and clinical interpretation. Journal of Psychoeducational Assessment,24(2), 172–178.
Pieretti, M., Zhang, F. P., Fu, Y. H., Warren, S. T., Oostra, B. A., Caskey, C. T., et al. (1991). Absence of expression of the FMR-1 gene in fragile X syndrome. Cell,66(4), 817–822.
Schalock, R. L., Brown, I., Brown, R., Cummins, R. A., Felce, D., Matikka, L., et al. (2002). Conceptualization, measurement, and application of quality of life for persons with intellectual disabilities: Report of an international panel of experts. Mental Retardation,40(6), 457–470.
Sparrow, S. S., & Cicchetti, D. V. (1985). Diagnostic uses of the Vineland Adaptive Behavior Scales. Journal of Pediatric Psychology,10(2), 215–225.
Varni, J. W., Burwinkle, T. M., & Lane, M. M. (2005). Health-related quality of life measurement in pediatric clinical practice: An appraisal and precept for future research and application. Health and Quality of Life Outcomes,3(1), 1.
Varni, J. W., Limbers, C., & Burwinkle, T. M. (2007a). Literature review: Health-related quality of life measurement in pediatric oncology: Hearing the voices of the children. Journal of Pediatric Psychology,32(9), 1151–1163.
Varni, J. W., Limbers, C. A., & Burwinkle, T. M. (2007b). Parent proxy-report of their children’s health-related quality of life: An analysis of 13,878 parents’ reliability and validity across age subgroups using the PedsQL™ 4.0 Generic Core Scales. Health and Quality of Life Outcomes,5(1), 1.
Varni, J. W., Seid, M., & Kurtin, P. S. (2001a). PedsQL 4.0: Reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Medical Care,39(8), 800–812.
Varni, J. W., Seid, M., & Kurtin, P. S. (2001b). PedsQL™ 4.0: Reliability and validity of the Pediatric Quality of Life Inventory™ Version 4.0 Generic Core Scales in healthy and patient populations. Medical Care,39(8), 800–812.
Varni, J. W., Seid, M., & Rode, C. A. (1999a). The PedsQL: Measurement model for the pediatric quality of life inventory. Medical Care,37(2), 126–139.
Varni, J. W., Seid, M., & Rode, C. A. (1999b). The PedsQL™: Measurement model for the pediatric quality of life inventory. Medical Care,37(2), 126–139.
Varni, J. W., Seid, M., Smith Knight, T., Burwinkle, T., Brown, J., & Szer, I. S. (2002). The PedsQL in pediatric rheumatology: Reliability, validity, and responsiveness of the Pediatric Quality of Life Inventory Generic Core Scales and Rheumatology Module. Arthritis and Rheumatism,46(3), 714–725.
Varni, J. W., Sherman, S. A., Burwinkle, T. M., Dickinson, P. E., & Dixon, P. (2004). The PedsQL™ family impact module: Preliminary reliability and validity. Health and Quality of Life Outcomes,2(1), 55.
Waters, E., Davis, E., Ronen, G. M., Rosenbaum, P., Livingston, M., & Saigal, S. (2009). Quality of life instruments for children and adolescents with neurodisabilities: How to choose the appropriate instrument. Developmental Medicine & Child Neurology,51(8), 660–669. https://doi.org/10.1111/j.1469-8749.2009.03324.x.
Wheeler, A. C., Skinner, D. G., & Bailey, D. B. (2008a). Perceived quality of life in mothers of children with fragile X syndrome. American Journal on Mental Retardation,113(3), 159–177.
Wheeler, A. C., Skinner, D. G., & Bailey, D. B. (2008b). Perceived quality of life in mothers of children with fragile X syndrome. American Journal of Mental Retardation,113(3), 159–177.
Funding
This work was supported by the Cincinnati Children’s Hospital Medical Center Research Foundation (CAE, EVP) and the Division of Child and Adolescent Psychiatry at Cincinnati Children’s Hospital Medical Center (CAE, EVP, KCD).
Author information
Authors and Affiliations
Contributions
SEF wrote the initial manuscript draft and participated in the analysis. LMM edited the manuscript and participated in the analysis. RA was the primary statistical analyst on the project and edited and wrote portions of the manuscript. EVP edited the manuscript, contributed to results interpretation and experiment conceptualization. LKW edited the manuscript, contributed to results interpretation and experiment conceptualization. KCD edited the manuscript, contributed to results interpretation and experiment conceptualization. RCS edited the manuscript, contributed to results interpretation and experiment conceptualization. JS edited the manuscript, participated in results interpretations, and facilitated data collection. JDW edited the manuscript, participated in results interpretations, and facilitated data collection. CAE conceptualized the experiments, participated in data collection, edited and wrote portions of the manuscript and is responsible for the project.
Corresponding author
Ethics declarations
Conflict of interest
No authors have a conflict financially or otherwise related to the content of this manuscript.
Ethical Approval
This research using online survey report involved analysis of deidentified data and therefore according to our local IRB does not constitute human subjects research requiring consent and local IRB approval and was determined to be exempt from such oversight.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Fitzpatrick, S.E., Schmitt, L.M., Adams, R. et al. Pediatric Quality of Life Inventory (PedsQL) in Fragile X Syndrome. J Autism Dev Disord 50, 1056–1063 (2020). https://doi.org/10.1007/s10803-019-04292-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10803-019-04292-7